COSCIENS Biopharma Balance Sheet (2016-2026)

Reported Financials

COSCIENS Biopharma Quarterly Balance Sheet

Periods 34 quarters

Latest Mar 2026

COSCIENS Biopharma reported total assets of $0.26M and total liabilities of $12.16M for the quarter ended Mar 2026, down 99.2% year over year. This balance sheet covers 34 quarters of results from Dec 2016 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	69.87M	68.00M	6.16M	63.60M	58.16M	53.82M	10.19M	9.29M	8.54M	8.36M	6.68M	3.51M	27.80M	20.00M	16.39M	13.76M	9.33M	8.52M	7.31M	0.03M
Cash & Current Investments	69.87M	68.00M	6.16M	63.60M	58.16M	53.82M	10.19M	9.29M	8.54M	8.36M	6.68M	3.51M	27.80M	20.00M	16.39M	13.76M	9.33M	8.52M	7.31M	0.03M
Receivables - NetNet Receivables	1.49M	0.91M	1.31M	0.69M	0.91M	0.78M	0.73M	0.56M	0.18M	0.55M	0.29M	0.19M	1.24M	1.89M	2.36M	1.86M	2.78M	1.60M	1.26M	0.05M
Receivables - OtherOther Receivables							0.12M				0.16M					0.16M
Receivables	1.49M	0.91M	1.31M	0.69M	0.91M	0.78M	0.86M	0.56M	0.18M	0.55M	0.45M	0.19M	1.24M	1.89M	2.36M	2.02M	2.78M	1.60M	1.26M	0.05M
Raw Materials											0.88M		0.77M	0.90M	0.74M	0.67M	0.78M	0.66M	0.58M
Finished Goods											0.54M		0.21M	0.31M	0.30M	0.20M	0.66M	0.36M	0.10M
Inventory	0.06M	0.06M	0.07M	0.28M	0.26M	0.24M	0.23M	0.23M	0.09M	0.09M	4.01M	0.06M	3.06M	3.31M	2.69M	2.46M	1.82M	1.76M	1.31M	0.05M
Prepaid Assets	4.38M	4.03M	1.77M	1.05M	2.46M	2.47M	2.00M	1.91M	2.64M	2.40M	0.29M	1.28M	0.99M	2.90M	2.43M	2.28M	2.57M	1.66M	1.59M	0.03M
Current Assets	74.73M	72.40M	70.82M	67.10M	63.17M	58.61M	55.49M	50.71M	45.89M	41.91M	11.27M	31.20M	33.21M	28.22M	23.98M	20.35M	16.50M	13.84M	11.50M	0.16M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.04M	0.04M	0.19M	0.04M	0.04M	0.04M	0.22M	0.25M	0.27M	0.26M	10.97M	0.27M	11.50M	11.81M	10.97M	10.66M	10.92M	9.89M	9.81M	0.04M
Goodwill	8.53M	8.33M	8.13M	7.98M	7.49M	7.03M
Intangibles	0.54M	0.64M	0.62M	0.61M	0.57M	0.54M	0.01M				0.01M		3.33M	1.81M
Goodwill & Intangibles	9.07M	8.97M	8.76M	8.59M	8.06M	7.57M	0.01M				0.01M		3.33M	1.81M
Long-Term Deferred Tax			0.98M								2.09M		0.95M	1.08M	1.32M
Other Non-Current Assets	0.08M	0.11M	0.02M	0.14M	0.12M	0.07M	0.06M				0.11M		0.31M	0.39M	0.21M	0.33M	0.32M	0.16M	0.18M
Non-Current Assets	9.62M	9.64M	9.28M	9.25M	8.65M	8.00M	-27.65M	0.57M	0.59M	0.57M	12.48M	0.60M	16.84M	15.55M	11.09M	10.79M	11.05M	10.02M	9.93M	0.10M
Assets	84.35M	82.04M	80.10M	76.34M	71.83M	66.61M	27.84M	51.28M	46.48M	42.49M	23.75M	31.79M	50.05M	43.77M	35.07M	31.14M	27.56M	23.86M	21.43M	0.26M
Liabilities
Current Liabilities
Accounts Payables	0.61M		0.93M	1.02M	0.94M	0.72M	2.04M	1.87M			0.28M	2.40M	3.58M	2.40M	2.41M	2.86M	1.53M	1.03M	0.74M
Payables	0.61M		0.93M	1.02M	0.94M	0.72M	2.04M	1.87M			0.28M	2.40M	3.58M	2.40M	2.41M	2.86M	1.53M	1.03M	0.74M
Accumulated Expenses			2.67M				3.83M	3.62M	3.57M	3.30M	1.01M	4.32M	5.84M	4.82M	4.73M	4.71M	3.06M	1.95M	1.88M	0.27M
Other Accumulated Expenses
Current Deferred Revenue			6.31M	5.37M	6.15M	4.95M	4.63M	3.79M	1.78M	1.74M
Total Current Liabilities	4.55M	4.78M	7.77M	5.67M	6.41M	5.97M	7.04M	6.43M	4.08M	4.23M	1.31M	5.25M	9.90M	8.17M	7.22M	7.06M	5.53M	3.98M	3.61M	0.48M
Non-Current Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax			0.98M
Operating Leases	0.01M	0.07M	0.03M	0.02M	0.02M	0.02M	0.07M	0.08M	0.09M	0.07M	1.40M	0.08M	1.28M	1.21M	2.04M	1.97M	2.05M	1.96M	1.93M	0.01M
Other Non-Current Liabilities			0.10M	0.10M	0.09M	0.09M	0.11M	0.11M	5.08M	5.08M
Total Non-Current Liabilities			19.35M	23.09M	17.44M	17.10M	13.21M	13.64M	13.33M	11.98M	1.40M	13.57M	13.92M	15.59M	14.69M	13.94M	14.93M	14.80M	13.98M	11.68M
Total Liabilities	23.06M	22.41M	58.17M	23.18M	17.53M	17.19M	4.02M	20.07M	23.11M	20.42M	2.71M	12.60M	23.82M	23.75M	21.91M	21.00M	20.46M	18.78M	17.59M	12.16M
Shareholder's Equity
Common Equity	61.29M	59.63M	21.94M	53.16M	54.29M	49.42M	23.82M	31.21M	23.37M	22.07M	21.04M	19.19M	26.23M	20.01M	13.16M	10.14M	7.10M	5.08M	3.84M	-11.90M
Liabilities and Shareholders Equity	84.35M	82.04M	80.10M	76.34M	71.83M	66.61M	27.84M	51.28M	46.48M	42.49M	23.75M	31.79M	50.05M	43.77M	35.07M	31.14M	27.56M	23.86M	21.43M	0.26M
Retained Earnings	-326.29M	-328.00M	-334.62M	-334.51M	-333.45M	-338.66M	-352.08M	-356.50M	-358.94M	-362.09M	4.36M	-375.26M	1.53M	-5.16M	-12.11M	-14.65M	-17.23M	-19.05M	-20.51M

COSCIENS Biopharma Balance Sheet API

Pull COSCIENS Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CSCIF&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "CSCIF", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=CSCIF&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

COSCIENS Biopharma CSCIF Balance Sheet (2016-2026)

COSCIENS Biopharma Quarterly Balance Sheet

COSCIENS Biopharma Balance Sheet API

Create an account

Sign In

Reset Password